IBDEI198 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22227,2)
 ;;=^339617
 ;;^UTILITY(U,$J,358.3,22228,0)
 ;;=786.30^^125^1389^22
 ;;^UTILITY(U,$J,358.3,22228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22228,1,4,0)
 ;;=4^786.30
 ;;^UTILITY(U,$J,358.3,22228,1,5,0)
 ;;=5^Hemoptysis
 ;;^UTILITY(U,$J,358.3,22228,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,22229,0)
 ;;=793.11^^125^1389^1
 ;;^UTILITY(U,$J,358.3,22229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22229,1,4,0)
 ;;=4^793.11
 ;;^UTILITY(U,$J,358.3,22229,1,5,0)
 ;;=5^Abn Chest Xray, Lung, Solitary Nodule
 ;;^UTILITY(U,$J,358.3,22229,2)
 ;;=^340570
 ;;^UTILITY(U,$J,358.3,22230,0)
 ;;=793.19^^125^1389^2
 ;;^UTILITY(U,$J,358.3,22230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22230,1,4,0)
 ;;=4^793.19
 ;;^UTILITY(U,$J,358.3,22230,1,5,0)
 ;;=5^Abn Chest Xray,Oth Finding, Lung
 ;;^UTILITY(U,$J,358.3,22230,2)
 ;;=^340571
 ;;^UTILITY(U,$J,358.3,22231,0)
 ;;=795.51^^125^1389^32
 ;;^UTILITY(U,$J,358.3,22231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22231,1,4,0)
 ;;=4^795.51
 ;;^UTILITY(U,$J,358.3,22231,1,5,0)
 ;;=5^Pos PPD w/o Active TB
 ;;^UTILITY(U,$J,358.3,22231,2)
 ;;=^340572
 ;;^UTILITY(U,$J,358.3,22232,0)
 ;;=795.52^^125^1389^31
 ;;^UTILITY(U,$J,358.3,22232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22232,1,4,0)
 ;;=4^795.52
 ;;^UTILITY(U,$J,358.3,22232,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,22232,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,22233,0)
 ;;=V15.82^^125^1389^21
 ;;^UTILITY(U,$J,358.3,22233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22233,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,22233,1,5,0)
 ;;=5^H/O Tobacco Abuse
 ;;^UTILITY(U,$J,358.3,22233,2)
 ;;=^303405
 ;;^UTILITY(U,$J,358.3,22234,0)
 ;;=511.89^^125^1389^27
 ;;^UTILITY(U,$J,358.3,22234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22234,1,4,0)
 ;;=4^511.89
 ;;^UTILITY(U,$J,358.3,22234,1,5,0)
 ;;=5^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,22234,2)
 ;;=^336604
 ;;^UTILITY(U,$J,358.3,22235,0)
 ;;=511.9^^125^1389^28
 ;;^UTILITY(U,$J,358.3,22235,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22235,1,4,0)
 ;;=4^511.9
 ;;^UTILITY(U,$J,358.3,22235,1,5,0)
 ;;=5^Pleural Effusion NOS
 ;;^UTILITY(U,$J,358.3,22235,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,22236,0)
 ;;=376.01^^125^1390^25
 ;;^UTILITY(U,$J,358.3,22236,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22236,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,22236,1,5,0)
 ;;=5^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,22236,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,22237,0)
 ;;=388.70^^125^1390^26
 ;;^UTILITY(U,$J,358.3,22237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22237,1,4,0)
 ;;=4^388.70
 ;;^UTILITY(U,$J,358.3,22237,1,5,0)
 ;;=5^Otalgia, Unsp
 ;;^UTILITY(U,$J,358.3,22237,2)
 ;;=^37811
 ;;^UTILITY(U,$J,358.3,22238,0)
 ;;=380.10^^125^1390^27
 ;;^UTILITY(U,$J,358.3,22238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22238,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,22238,1,5,0)
 ;;=5^Otitis Externa,Infect
 ;;^UTILITY(U,$J,358.3,22238,2)
 ;;=^62807
 ;;^UTILITY(U,$J,358.3,22239,0)
 ;;=381.01^^125^1390^31
 ;;^UTILITY(U,$J,358.3,22239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22239,1,4,0)
 ;;=4^381.01
 ;;^UTILITY(U,$J,358.3,22239,1,5,0)
 ;;=5^Otitis Media, Serous Acute
 ;;^UTILITY(U,$J,358.3,22239,2)
 ;;=^269369
 ;;^UTILITY(U,$J,358.3,22240,0)
 ;;=382.9^^125^1390^28
 ;;^UTILITY(U,$J,358.3,22240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22240,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,22240,1,5,0)
 ;;=5^Otitis Med, Other Acute
 ;;^UTILITY(U,$J,358.3,22240,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,22241,0)
 ;;=382.01^^125^1390^30
 ;;^UTILITY(U,$J,358.3,22241,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI198
